Abstract

The continued diversification of HIV poses potentially significant challenges to HIV diagnostics and therapeutics. The dynamic evolution of emerging variants is highlighted in countries such as Cameroon in West Central Africa, where all known subtypes and circulating recombinant forms (CRFs) have been shown to be prevalent. We obtained several hundred HIV-positive plasma and viruses from this region for characterization and identification of highly divergent HIV strains. A total of 163 viral strains were cultured to high titers and high volumes using donor peripheral blood mononuclear cells (PBMCs). Initially, 101 viruses representing 59 strains were well characterized and categorized. Results showed that the viral load (VL) range was 0.36–398.9 × 107 copies/mL, p24 values was 0.2–1134 ng/mL. Phylogenetic analysis of thirty-six near full-length HIV-1 genomic sequences demonstrated that most recombinants were highly diverse CRF02 containing unique recombinant forms (URFs). There were seven viral isolates identified as pure subtype/sub-subtypes (F2, A1, G, and D), six as CRFs (CRF06, CRF18, and CRF22), and ten as URFs. These extensively characterized reagents reflect the current dynamic and complex HIV epidemic in Cameroon and provide valuable insights into the potential phylogenetic evolutionary trend of global HIV molecular epidemiology in the future. These materials may be useful for development of HIV validation and reference panels to evaluate the performance of serologic antigen and nucleic acid assays for their ability to detect and quantitate highly divergent HIV strains.

Highlights

  • Introduction iationsThe continued diversification and evolution of HIV poses significant challenges to diagnostics and therapeutics [1,2,3]

  • The supernatant containing HIV particles was directly tested for p24 value prior to store as neat culture supernatant at −80 ◦ C

  • According to prior genotyping data obtained from plasma specimens, currently cultured viral stocks include four isolates identified as subtypes (B, D, G), five as sub-subtypes (A1 and F2), seven as circulating recombinant forms (CRFs) (02, 06, 09, 18, 22, and 36), and many as unique recombinant forms (URFs) (01+22, 02+09, 02+22; 02+36, G+02, B+22, A1+G+02, B+02, D+02, F2+02, 01+02)

Read more

Summary

Introduction

The continued diversification and evolution of HIV poses significant challenges to diagnostics and therapeutics [1,2,3]. Recent studies demonstrated that HIV-1 subtypes and major recombinants should be considered in the evaluation of new HIV therapeutics, prevention modalities, and vaccines [4]. Study of the diversity and evolution of HIV is essential for development of reference material to improve diagnostics and for pandemic preparedness. Cameroon is a country in West Central Africa where HIV-1 infection is pandemic, and the natural reservoir of HIV-1 group M, N, O and P has been identified. The genetic diversity of HIV-1 appears wide-ranging in Cameroon where all group M clades and CRFs including CRF01_AE(01), CRF02_AG(02), CRF06_cpx(06), Licensee MDPI, Basel, Switzerland

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call